Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Kominox (sodium metaarsenite)
i
Other names:
KML001, KML-001, NaAsO2, KML 001
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Komipharm
Drug class:
Telomerase inhibitor, NF-κB inhibitor, VEGF-C inhibitor
Related drugs:
‹
tretinoin (6)
BIBR1532 (1)
tertomotide (1)
THIO (0)
GX301 (0)
imetelstat (0)
suratadenoturev (0)
VAC2 (0)
bisantrene (0)
SBI-756 (2)
BAY-61-3606 (1)
DC-1-192 (1)
CBL0102 (1)
SBI-726 (1)
omtriptolide (1)
ascorbic acid/menadione (0)
Bay11-7082 (0)
BMX-001 (0)
iMX-110 (0)
ETS2101 (0)
ACT001 (0)
antroquinonol (0)
KLTi (0)
GP-2250 (0)
PBI-05204 (0)
piceatannol (0)
efprezimod alfa (0)
SR13668 (0)
bezisterim (0)
squalamine (0)
MSB0254 (0)
tretinoin (6)
BIBR1532 (1)
tertomotide (1)
THIO (0)
GX301 (0)
imetelstat (0)
suratadenoturev (0)
VAC2 (0)
bisantrene (0)
SBI-756 (2)
BAY-61-3606 (1)
DC-1-192 (1)
CBL0102 (1)
SBI-726 (1)
omtriptolide (1)
ascorbic acid/menadione (0)
Bay11-7082 (0)
BMX-001 (0)
iMX-110 (0)
ETS2101 (0)
ACT001 (0)
antroquinonol (0)
KLTi (0)
GP-2250 (0)
PBI-05204 (0)
piceatannol (0)
efprezimod alfa (0)
SR13668 (0)
bezisterim (0)
squalamine (0)
MSB0254 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
AKT1 overexpression
Glioblastoma
AKT1 overexpression
Glioblastoma
sodium metaarsenite
Sensitive: D – Preclinical
sodium metaarsenite
Sensitive
:
D
sodium metaarsenite
Sensitive: D – Preclinical
sodium metaarsenite
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.